Dr. Martens, the iconic British footwear brand, announces today that an investment vehicle backed by the Permira Funds has agreed to acquire R Griggs Group Limited, the parent company and licensee in perpetuity of the Dr Martens brand for £300m. The deal is expected to complete in January 2014.
Dr. Martens is a global brand with a rich and diverse heritage and a contemporary relevance. Headquartered in Northants on the site of the original factory, it is sold in 63 countries, principally in the US, Asia, Europe and the UK. The company’s deep-rooted links with the working class, music, subcultures and self-expression have kept the brand at the forefront of youth culture for over 50 years.
Click the PDF icon to download the full release.